11.40
0.71%
+0.08
After Hours:
11.40
Sotera Health Co stock is currently priced at $11.40, with a 24-hour trading volume of 734.67K.
It has seen a +0.71% increased in the last 24 hours and a -1.13% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $11.31 pivot point. If it approaches the $11.62 resistance level, significant changes may occur.
Previous Close:
$11.32
Open:
$11.33
24h Volume:
734.67K
Market Cap:
$3.23B
Revenue:
$1.05B
Net Income/Loss:
$51.38M
P/E Ratio:
-10.36
EPS:
-1.1
Net Cash Flow:
$-362.71M
1W Performance:
+4.11%
1M Performance:
-1.13%
6M Performance:
-10.09%
1Y Performance:
-30.19%
Sotera Health Co Stock (SHC) Company Profile
Name
Sotera Health Co
Sector
Industry
Phone
440-262-1410
Address
9100 South Hills Boulevard, Suite 300, Broadview Heights
Sotera Health Co Stock (SHC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
Jun-26-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Jan-23-23 | Upgrade | JP Morgan | Underweight → Neutral |
Jan-11-23 | Upgrade | Barclays | Underweight → Overweight |
Jan-11-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Nov-15-22 | Downgrade | Barclays | Equal Weight → Underweight |
Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
Sep-26-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Sep-21-22 | Downgrade | JP Morgan | Overweight → Underweight |
Sep-20-22 | Downgrade | Goldman | Buy → Neutral |
Jun-09-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Apr-06-22 | Initiated | Wolfe Research | Outperform |
Mar-03-22 | Downgrade | Jefferies | Buy → Hold |
Mar-02-22 | Downgrade | Barclays | Overweight → Equal Weight |
Mar-03-21 | Initiated | Barclays | Overweight |
Jan-14-21 | Initiated | Robert W. Baird | Outperform |
Dec-15-20 | Initiated | Citigroup | Buy |
Dec-15-20 | Initiated | Credit Suisse | Outperform |
Dec-15-20 | Initiated | Goldman | Buy |
Dec-15-20 | Initiated | JP Morgan | Overweight |
Dec-15-20 | Initiated | Jefferies | Buy |
Dec-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
Dec-15-20 | Initiated | RBC Capital Mkts | Outperform |
View All
Sotera Health Co Stock (SHC) Latest News
Sotera Health Company (SHC) Reports Next Week: Wall Street Expects Earnings Growth
Zacks Investment Research
Sotera Health Announces First-Quarter 2024 Earnings Release Date
GlobeNewswire Inc.
Analyst Scoreboard: 6 Ratings For Sotera Health
Benzinga
A Glimpse Into The Expert Outlook On Sotera Health Through 4 Analysts
Benzinga
Sotera Health Announces Pricing of Secondary Offering
GlobeNewswire Inc.
Barclays Maintains Overweight Rating for Sotera Health: Here's What You Need To Know
Benzinga
Sotera Health Co Stock (SHC) Financials Data
Sotera Health Co (SHC) Revenue 2024
SHC reported a revenue (TTM) of $1.05 billion for the quarter ending December 31, 2023, a +4.54% rise year-over-year.
Sotera Health Co (SHC) Net Income 2024
SHC net income (TTM) was $51.38 million for the quarter ending December 31, 2023, a +122.00% increase year-over-year.
Sotera Health Co (SHC) Cash Flow 2024
SHC recorded a free cash flow (TTM) of -$362.71 million for the quarter ending December 31, 2023, a -479.47% decrease year-over-year.
Sotera Health Co (SHC) Earnings per Share 2024
SHC earnings per share (TTM) was $0.18 for the quarter ending December 31, 2023, a +121.69% growth year-over-year.
About Sotera Health Co
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the United States and internationally. Its sterilization services include gamma and electron beam irradiation, and EO processing; and lab services comprise analytical chemistry, medical device, and pharmaceutical lab testing, as well as microbiology testing. The company also provides Co-60 and gamma irradiators, which are principal components to the gamma sterilization process. Its microbiology testing services help customers to identify and measure the potential risks of microbes to a product and ensure that the quality of the products is maintained; and advisory services help customers in navigating the regulatory requirements applicable throughout the product lifecycle. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is based in Broadview Heights, Ohio.
Cap:
|
Volume (24h):